HUP0302585A2 - Egy egyén allergiás reakcióra való hajlamának csökkentésére képes tejsavbaktériumok - Google Patents

Egy egyén allergiás reakcióra való hajlamának csökkentésére képes tejsavbaktériumok

Info

Publication number
HUP0302585A2
HUP0302585A2 HU0302585A HUP0302585A HUP0302585A2 HU P0302585 A2 HUP0302585 A2 HU P0302585A2 HU 0302585 A HU0302585 A HU 0302585A HU P0302585 A HUP0302585 A HU P0302585A HU P0302585 A2 HUP0302585 A2 HU P0302585A2
Authority
HU
Hungary
Prior art keywords
tendency
individual
develop
lactic acid
acid bacteria
Prior art date
Application number
HU0302585A
Other languages
English (en)
Inventor
Blaise Corthesy
Rodolphe Fritsche
Jacques Edouard Germond
Beat Mollet
Original Assignee
Société des Produits Nestlé S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Société des Produits Nestlé S.A. filed Critical Société des Produits Nestlé S.A.
Publication of HUP0302585A2 publication Critical patent/HUP0302585A2/hu
Publication of HUP0302585A3 publication Critical patent/HUP0302585A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1236—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C2220/00—Biochemical treatment
    • A23C2220/20—Treatment with microorganisms
    • A23C2220/202—Genetic engineering of microorganisms used in dairy technology
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/151—Johnsonii
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/231—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)

Abstract

A találmány tárgyát tejsavbaktériumok új törzsei képezik, amelyekképesek csökkenteni egy egyén hajlamát allergiás reakciókkialakítására. Közelebbről, a találmány tárgyát tejsavbaktériumokolyan új törzseinek előállítása képezi, amelyek tolerogén peptidekettartalmazó fehérjéket expresszálnak, és azok alkalmazását egy egyénallergiás reakciók kialakítására való hajlamának csökkentésére. Atalálmány tárgyát képezik élelmiszer- és gyógyászati készítmények is,amelyek tartalmazzák ezeket a mikroorganizmusokat vagy azok frakcióit. Ó
HU0302585A 2000-09-25 2001-09-21 Lactic acid bacteria capable of reducing an individual's tendency to develop allerreactions HUP0302585A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00120867 2000-09-25
PCT/EP2001/010956 WO2002024883A2 (en) 2000-09-25 2001-09-21 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions

Publications (2)

Publication Number Publication Date
HUP0302585A2 true HUP0302585A2 (hu) 2003-10-28
HUP0302585A3 HUP0302585A3 (en) 2007-05-02

Family

ID=8169939

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302585A HUP0302585A3 (en) 2000-09-25 2001-09-21 Lactic acid bacteria capable of reducing an individual's tendency to develop allerreactions

Country Status (21)

Country Link
US (1) US7498162B2 (hu)
EP (1) EP1379635A2 (hu)
JP (1) JP2004514424A (hu)
KR (1) KR20030034178A (hu)
CN (1) CN1246456C (hu)
AR (1) AR033574A1 (hu)
AU (2) AU2056102A (hu)
BG (1) BG107657A (hu)
BR (1) BR0114105A (hu)
CA (1) CA2420160A1 (hu)
CZ (1) CZ2003749A3 (hu)
HU (1) HUP0302585A3 (hu)
IL (1) IL154284A0 (hu)
MX (1) MXPA03001673A (hu)
NO (1) NO20031159L (hu)
NZ (1) NZ524527A (hu)
PL (1) PL365246A1 (hu)
RU (1) RU2294366C2 (hu)
SK (1) SK3642003A3 (hu)
WO (1) WO2002024883A2 (hu)
ZA (1) ZA200301244B (hu)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
EP1319410A1 (en) * 2001-12-11 2003-06-18 Société des Produits Nestlé S.A. Use of micro-organisms for a directed delivery of substances to specific parts of the gut
WO2004112773A1 (fr) * 2003-04-24 2004-12-29 Shin-Jen Shiao Compositions pharmaceutiques utilisees pour le traitement de maladie immune et amelioration
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
EP1824973A1 (en) * 2004-12-14 2007-08-29 Alk-Abello A/S Pharmaceutical composition comprising a bacterial cell displaying a heterologous proteinaceous compound
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
BRPI0611493B1 (pt) 2005-05-31 2022-04-05 Alimentary Health Ltd. Lactobacilos probióticos felinos
EP2003989A1 (en) * 2006-03-31 2008-12-24 DSMIP Assets B.V. Process for the hydrolysis of milk proteins
CA2673465A1 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
CA2749964A1 (en) * 2009-01-27 2010-08-05 Arla Foods Amba Long shelf life milk and milk-related products, and a process and milk processing plant for their manufacture
BRPI1014304A2 (pt) * 2009-05-11 2016-04-05 Nestec Sa bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP3338565A1 (en) * 2010-06-04 2018-06-27 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
EP3282260B1 (en) * 2011-09-02 2019-12-11 DH Technologies Development Pte. Ltd. System and method for detection of lactoglobulin
WO2013083140A1 (en) 2011-12-07 2013-06-13 N.V. Nutricia Beta-lactoglobulin peptides for treating cow's milk protein allergy
WO2016148562A1 (en) * 2015-03-18 2016-09-22 N.V. Nutricia Method for inducing oral tolerance via administration of beta-lactoglobulin derived peptide in combination with probiotic
CN105362296A (zh) * 2015-11-27 2016-03-02 成都吉氧屋科技有限公司 乳酸菌洗鼻液
WO2019212329A1 (en) * 2018-04-30 2019-11-07 N.V. Nutricia Formula with specific beta-lactoglobulin peptides
WO2019212330A1 (en) * 2018-04-30 2019-11-07 N.V. Nutricia Formula with a specific beta-lactoglobulin peptide
CN114149486B (zh) * 2021-05-28 2023-05-12 中国科学院大连化学物理研究所 一种抗菌肽mamp-01及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302855D0 (sv) * 1993-09-06 1993-09-06 Martin Lindberg Method and means for producing plasmaproteinase inhibitor binding proteins
US5817308A (en) 1994-02-14 1998-10-06 University Of Rochester Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance
WO1996032486A1 (en) * 1995-04-11 1996-10-17 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for the construction of vectors for lactic acid bacteria like lactobacillus such that the bacteria can efficiently express, secrete and display proteins at the surface
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
GB9518323D0 (en) * 1995-09-07 1995-11-08 Steidler Lothar Materials and methods relating to the attachment and display of substances on cell surfaces
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
MY129566A (en) 1999-01-19 2007-04-30 Nestle Sa A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance

Also Published As

Publication number Publication date
US20040071714A1 (en) 2004-04-15
NO20031159L (no) 2003-05-20
JP2004514424A (ja) 2004-05-20
AR033574A1 (es) 2003-12-26
BR0114105A (pt) 2003-07-29
CN1479788A (zh) 2004-03-03
RU2294366C2 (ru) 2007-02-27
NO20031159D0 (no) 2003-03-13
NZ524527A (en) 2005-05-27
AU2002220561C1 (en) 2002-04-02
WO2002024883A3 (en) 2003-11-06
SK3642003A3 (en) 2003-08-05
US7498162B2 (en) 2009-03-03
BG107657A (bg) 2003-12-31
AU2002220561B2 (en) 2007-01-11
CA2420160A1 (en) 2002-03-28
KR20030034178A (ko) 2003-05-01
EP1379635A2 (en) 2004-01-14
PL365246A1 (en) 2004-12-27
IL154284A0 (en) 2003-09-17
CZ2003749A3 (cs) 2003-06-18
AU2056102A (en) 2002-04-02
MXPA03001673A (es) 2003-06-09
ZA200301244B (en) 2004-05-14
HUP0302585A3 (en) 2007-05-02
CN1246456C (zh) 2006-03-22
WO2002024883A2 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
HUP0302585A2 (hu) Egy egyén allergiás reakcióra való hajlamának csökkentésére képes tejsavbaktériumok
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
HUP0203185A2 (hu) Vérnyomáscsökkentő di- és tripeptideket termelő Lactobacillus helveticus
HUP0303854A2 (hu) Szintetikus erythropoiesis-stimuláló proteinek
HUP0303996A2 (hu) Vakcinakészítmények
BR0113822A (pt) Vacina
AU3368497A (en) Human dnase i hyperactive variants
FI964681A (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
HUP9802525A1 (hu) Hüvelyfertőzések kezelésére szolgáló, lactobacillus tartalmú gyógyászati készítmények
SE0402406D0 (sv) Probiotic lactobacillus strains for improved vaginal health
AU2001254624A1 (en) Human coagulation factor vii variants
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
IL172506A0 (en) New biological entities and the use thereof
PT749317E (pt) Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade
WO2004007695A3 (en) Lactobacilli expressing biologically active polypeptides and uses thereof
HUP0301349A2 (hu) IL-11-tartalmú készítmények
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
HUP0302481A2 (hu) Virulencia gének, fehérjék és alkalmazásuk
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
HUP0203740A2 (en) Food product and process
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
IL143956A0 (en) Chimeric gene encoding the antigenic determinants of four proteins of l.infantum
ATE315092T1 (de) Acetylhydrolase des plättchen aktivierenden faktors, und entsprechendes gen
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees